Site Map Site Map of http://www.researchandmarkets.com - Site Map - Pharmaceuticals and Healthcare    - Pharmaceuticals 1 (Latest Titles)    Pharmaceuticals 2    Pharmaceuticals 3    Pharmaceuticals 4    Pharmaceuticals 5       - Drug Discovery  << You are in This Category #  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z   A A Concise Guide to Clinical Trials static version printer friendly pdf version A Guide to Business & Regulatory Strategies: Companion Diagnostic Prod... static version printer friendly A Guide to Evaluating and Choosing CROs static version printer friendly pdf version A Product Director’s Guide to Promotional Mix static version printer friendly pdf version Accelerating Lead Generation: Emerging Technologies and Strategies static version printer friendly pdf version Achieving Market Dominance Through Reformulation: A Strategic Insight static version printer friendly Advances in RNAi--A Global Technology Assessment (Technical Insights) static version printer friendly pdf version Advancing Drug Discovery Through Structure-Guided Drug Design static version printer friendly Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery static version printer friendly pdf version Analysis of Prostate Cancer R&D: The Complete Guide static version printer friendly Angiogenesis Modulators: Strategies for Drug Discovery static version printer friendly pdf version Angiotensin as a target for the treatment of Alzheimer's disease, anxi... static version printer friendly Antibiotics and Drug Resistance static version printer friendly pdf version Antibody Therapeutics: Product Development, Market Trends, and Strateg... static version printer friendly pdf version Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets... static version printer friendly pdf version Antisense Therapy: Technical Aspects and Commercial Opportunities static version printer friendly Applications of Stem Cells in Drug Discovery static version printer friendly Assay Development and Technologies, 2nd Edition static version printer friendly pdf version Aurora Kinase inhibitors - The dawn of a new approach to cancer static version printer friendly Autoimmune Treatment (2009 - 2014) static version printer friendly pdf version ^ Top B Bio/Pharma R&D Statistical Sourcebook 2008/2009 static version printer friendly pdf version Biochips in Drug Discovery in Europe static version printer friendly pdf version Biomanufacturing Strategies: Market Drivers, Build-vs-Buy Decisions an... static version printer friendly pdf version Biomarkers: The Future of Next-Generation Drug R&D static version printer friendly pdf version BioMed Outsourcing Report-Drug Discovery Partnerships-The Indian Bioph... static version printer friendly Biomed Outsourcing Report: Drug Discovery and Development Partnerships... static version printer friendly Biopartnering Strategies: Maximizing returns from biotechnology deal-m... static version printer friendly pdf version Biosimilars Series: Strategic Issues - Potential Remains Uncertain static version printer friendly pdf version Booming Global Obesity Drug Market static version printer friendly pdf version Building on Early Successes of Immunomodulators in the Fight Against C... static version printer friendly pdf version ^ Top C c-MET/HGF Inhibitors – Target and Company Pipelines static version printer friendly pdf version Cancer Drug Discoveries: What the Future Holds static version printer friendly Cancer Vaccine Developments to 2013 + Cancer Vaccine Tracker static version printer friendly pdf version Cell-Based Assays for Drug Discovery static version printer friendly pdf version Chemical Genetics in Drug Discovery static version printer friendly pdf version Clinical Trials Handbook static version printer friendly pdf version Clinical Trials in India static version printer friendly pdf version Clinical Trials in Poland 2008. Development Forecasts for 2008-2010 static version printer friendly pdf version Clinical Trials in Poland 2008. Development Forecasts for 2008-2010 static version printer friendly pdf version Clinical Trials in Russia 2008. Russia Compared to Other Countries static version printer friendly pdf version Clinical Trials Market in Russia static version printer friendly pdf version Clinical Trials: Exploring Wireless Opportunities static version printer friendly CNS Drug Discoveries: Alzheimer's Disease Chapter static version printer friendly pdf version CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder Chapter... static version printer friendly pdf version CNS Drug Discoveries: Depression Chapter static version printer friendly pdf version CNS Drug Discoveries: Multiple Sclerosis Chapter static version printer friendly pdf version CNS Drug Discoveries: Parkinson's Disease Chapter static version printer friendly pdf version CNS Drug Discoveries: Schizophrenia Chapter static version printer friendly pdf version CNS Drug Discoveries: What the Future Holds 2008 static version printer friendly pdf version Commercial and Pipeline Insight: Infertility - Optimizing a market bou... static version printer friendly pdf version Commercial Insight: Antidiabetics - Billion Dollar Drugs, Pipeline Dre... static version printer friendly Commercial Insight: Upper GI Disorders - Innovation needed to overcome... static version printer friendly pdf version Commercial Opportunities from Biomarkers: Transforming drug discovery,... static version printer friendly pdf version Competition Driving Breakthroughs in Sports Medicine Market static version printer friendly pdf version Competitor Analysis: Alzheimer’s Disease Antibodies static version printer friendly pdf version Competitor Analysis: Antithrombotics static version printer friendly pdf version Competitor Analysis: Antiviral Antibodies static version printer friendly pdf version Competitor Analysis: Cannabinoid CB1 Receptor Antagonists static version printer friendly pdf version Competitor Analysis: CD20 Antibodies static version printer friendly pdf version Competitor Analysis: Diabetes Drug Pipeline static version printer friendly pdf version Competitor Analysis: Dipeptidyl Peptidase IV (DPP-IV) Inhibitors static version printer friendly pdf version Competitor Analysis: Emerging Diabetes Drugs static version printer friendly pdf version Competitor Analysis: Enzyme Replacement Therapies static version printer friendly pdf version Competitor Analysis: Follicle Stimulating Hormone (FSH) static version printer friendly pdf version Competitor Analysis: GLP-1 Receptor Agonists static version printer friendly pdf version Competitor Analysis: HDL Raising Therapies static version printer friendly pdf version Competitor Analysis: Human Growth Hormone (hGH) static version printer friendly pdf version Competitor Analysis: Immunotherapy of S. aureus Infections static version printer friendly pdf version Competitor Analysis: Insulin static version printer friendly pdf version Competitor Analysis: Integrin Antagonists static version printer friendly pdf version Competitor Analysis: Interferon static version printer friendly pdf version Competitor Analysis: Janus Kinase (JAK) Inhibitors static version printer friendly pdf version Competitor Analysis: PDGF-R Agonists and Antagonists static version printer friendly pdf version Competitor Analysis: Plk-1 Inhibitors static version printer friendly pdf version Competitor Analysis: PPAR Agonists static version printer friendly pdf version Competitor Analysis: Raf Inhibitors static version printer friendly pdf version Competitor Analysis: Sodium-Dependent Glucose (Co-) Transporter (SGLT)... static version printer friendly pdf version Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO) static version printer friendly pdf version Competitor Analysis: Toll-Like Receptor (TLR) Agonists & Antagonists static version printer friendly pdf version Computational Chemistry: A Tool for Feeding R&D Pipelines static version printer friendly pdf version Concepts in Genetic Medicine static version printer friendly pdf version Conducting Clinical Trials in Emerging Markets static version printer friendly pdf version Contract Research Organization Market- What Pharmaceutical and Biotech... static version printer friendly pdf version COPD Drug Discovery: How New Generation Therapies Seek to Target Under... static version printer friendly COX-2 Inhibitors - Biology, Therapeutic Agents & Markets static version printer friendly COX-2 withdrawal - Therapeutic, R&D and pharmaceutical impact static version printer friendly CRA Training Series (7 Volume Set) (2000) static version printer friendly pdf version CRA Training Series Vol. 1 - An Overview of Drug Development (2000) static version printer friendly CRA Training Series Vol. 2 - Identifying and Screening Investigators (... static version printer friendly CRA Training Series Vol. 3 - Conducting the Pre-Study Visit (2000) static version printer friendly CRA Training Series Vol. 4 - Conducting the Study Initiation Visits (2... static version printer friendly CRA Training Series Vol. 5 - Conducting Routine Monitoring Visits (200... static version printer friendly CRA Training Series Vol. 6 - The CRA's Reference for Adverse Events (2... static version printer friendly CRA Training Series Vol. 7 - Test Your Knowledge (2000) static version printer friendly Current Clinical Trials: Rheumatology static version printer friendly pdf version Current Drug Development Market for Cytokines, Chemokines and Growth F... static version printer friendly pdf version ^ Top D Dendritic Cells: Targets for Immunotherapy static version printer friendly Development and Approval of Combination Products: A Regulatory Perspec... static version printer friendly pdf version Developments in Pharmaceutical Microencapsulation in the United States... static version printer friendly pdf version Disease and Therapy Review: Alzheimer's Disease static version printer friendly pdf version Disease and Therapy Review: Constipation static version printer friendly pdf version Disease and Therapy Review: Crohn's Disease static version printer friendly pdf version Disease and Therapy Review: End Stage Renal Disease static version printer friendly pdf version Disease and Therapy Review: High Cholesterol static version printer friendly pdf version Disease and Therapy Review: Irritable Bowel Syndrome static version printer friendly pdf version Disease and Therapy Review: Multiple Sclerosis static version printer friendly pdf version Disease and Therapy Review: Neuropathic Pain static version printer friendly pdf version Disease and Therapy Review: Rheumatoid Arthritis static version printer friendly pdf version Disease and Therapy Review: Schizophrenia static version printer friendly pdf version Disease and Therapy Review: Senile Dementia static version printer friendly pdf version Disease and Therapy Review: Systemic Lupus Erythematosus static version printer friendly pdf version Disease and Therapy Review: Urinary Incontinence static version printer friendly pdf version Does the Treatment of Huntington's Disease Represent a Commercial Oppo... static version printer friendly pdf version Drug Development Opportunities in China: Regulation, Key Players and I... static version printer friendly pdf version Drug Discovery for Nervous System Diseases static version printer friendly pdf version Drug Discovery Markets in Asia Pacific static version printer friendly pdf version Drug Discovery Outsourcing Market in India and China static version printer friendly pdf version Drug Discovery Research: New Frontiers in the Post-Genomic Era static version printer friendly pdf version Drug Discovery Technologies & Platforms - Speed up your preclinical re... static version printer friendly Drug Discovery Technologies - A Global Update of Market Trends & Oppor... static version printer friendly pdf version Drug Discovery Technologies - Global Strategic Business Report static version printer friendly pdf version Drug Discovery Tools for High-Content Analysis static version printer friendly pdf version Drug Discovery--European Advances in Genomics and Proteomics (Technica... static version printer friendly pdf version Drug Discovery: A History static version printer friendly Drug Efficacy, Safety, and Biologics Discovery: Emerging Technologies ... static version printer friendly pdf version Drug Metabolism Handbook: Concepts and Applications static version printer friendly pdf version Drug Metabolism in Drug Design and Development static version printer friendly pdf version Drug Registration In China-An overview of China Drug Registration Proc... static version printer friendly pdf version Drug Repositioning Strategies: Innovative Strategies to Boost Pipeline... static version printer friendly pdf version Drug Safety Evaluation, 2nd Edition static version printer friendly pdf version Drug Targets from Genomics: Evolving Tools for Discovery static version printer friendly Drug-DNA Interactions: Structures and Spectra static version printer friendly pdf version Drug-Drug Interactions in Pharmaceutical Development static version printer friendly pdf version Drug-Induced Mitochondrial Dysfunction static version printer friendly pdf version Drugs for Medical Use Approved for Cosmetic Use static version printer friendly pdf version Drugs of Tommorow 2002: Breast Cancer static version printer friendly Drugs of Tommorrow 2002: Pain static version printer friendly pdf version Drugs of Tomorrow 2000 Vaccines: A New Era of Disease Targets static version printer friendly Drugs of Tomorrow 2000: Allergic Rhinitis - New Drug Classes, Towards ... static version printer friendly pdf version Drugs of Tomorrow 2000: Arthritis - Developments For a Competitive Mar... static version printer friendly pdf version Drugs of Tomorrow 2000: Lung Cancer - New Partners For Old Regimens static version printer friendly Drugs of Tomorrow 2000: Prostate Cancer - Hormonals and Beyond static version printer friendly Drugs of Tomorrow 2001: Anticoagulants - A pipeline flowing with futur... static version printer friendly Drugs of Tomorrow 2001: Antipsychotics - New Players in an Expanding M... static version printer friendly Drugs of Tomorrow 2001: Bacterial Infections static version printer friendly Drugs of Tomorrow 2001: Cancer Overview static version printer friendly Drugs of Tomorrow 2001: Depression - A Future Away From Serotonin? static version printer friendly Drugs of Tomorrow 2001: Diabetes static version printer friendly Drugs of Tomorrow 2001: Dyslipidemia - The Advent of Third Generation ... static version printer friendly Drugs of Tomorrow 2001: Hepatitis - The Succession of New Generation T... static version printer friendly pdf version Drugs of Tomorrow 2001: Hypertension - The Mounting Pressures Facing N... static version printer friendly Drugs of Tomorrow 2001: Lung Cancer static version printer friendly Drugs of Tomorrow 2001: Migraine - Impact of the Novel Triptan Class o... static version printer friendly Drugs of Tomorrow 2001: Neuroprotection - Future Strategies for Succes... static version printer friendly Drugs of Tomorrow 2001: Stable Angina - An Unsatisfactory R&D Pipeline... static version printer friendly Drugs of Tomorrow 2002: Arthritis static version printer friendly pdf version Drugs of Tomorrow 2002: Colorectal Cancer static version printer friendly Drugs of Tomorrow 2002: Depression - A pipeline driven by side effect ... static version printer friendly pdf version Drugs of Tomorrow 2002: Reperfusion Injury - The Next Breakthrough in ... static version printer friendly Drugs of Tomorrow: Anti-asthmatics - Enter the mAbs static version printer friendly Drugs of Tomorrow: Cancer Overview static version printer friendly Drugs of Tomorrow: Cancer Overview - The synergistic advance: innovati... static version printer friendly Drugs: From Discovery to Approval, 2nd Edition static version printer friendly Due Diligence in Life Science Transactions, 2nd Edition static version printer friendly pdf version ^ Top E Early Stage Drug Safety Strategies and Risk Management: Maximizing Opp... static version printer friendly pdf version Emerging Drug Discovery Technologies: Building competitive advantage t... static version printer friendly Emerging Drug Targets in Alzheimer's Disease static version printer friendly pdf version Emerging Opportunities in Controlled-Release Generic Drugs static version printer friendly pdf version Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs static version printer friendly pdf version Emerging Opportunities with Cannabinoids static version printer friendly pdf version Emerging Pharmaceutical Markets: Growth Opportunities, Changing Health... static version printer friendly pdf version Ethical Issues in Drug Development:A Deterrent To Fraud and other Malf... static version printer friendly pdf version European Cell Based Assays Markets static version printer friendly pdf version European Generic Drug Market Potential static version printer friendly pdf version European Urinary Incontinence Therapeutics Markets static version printer friendly pdf version ^ Top F Formulation and Analytical Development for Low-Dose Oral Drug Products... static version printer friendly pdf version Fragment-Based Drug Discovery: A Practical Approach static version printer friendly pdf version Fueling the Drug Discovery Engine: Biotech Investment and Business Tre... static version printer friendly pdf version ^ Top G G-Protein Coupled Receptors (GPCRs): Technical Overview, Emerging Tech... static version printer friendly Gastrointestinal Drug Discoveries: What the Future Holds static version printer friendly pdf version Generic Series: Benchmarking Patent Expiries - Key Factors Affecting B... static version printer friendly pdf version Genomics in Drug Discovery and Development static version printer friendly pdf version Genomics Players: From Discovery to Integration- Business and Technolo... static version printer friendly pdf version Genomics: Pharmaceutical Investment, Integration and Partnerships static version printer friendly Global Market for Plant Derived Drugs, 2005-2012 static version printer friendly pdf version Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery ... static version printer friendly pdf version Glycogen synthase kinase 3 inhibitors: Proof of concept and therapeuti... static version printer friendly ^ Top H Herg: Technology and Market Analysis static version printer friendly High Content Screening: Science, Techniques and Applications static version printer friendly pdf version High-tech immunization static version printer friendly How Overcoming the Challenge of Biomarker Validation Can Pay Off for D... static version printer friendly pdf version Hypoglycaemia in Clinical Diabetes, 2nd Edition static version printer friendly pdf version ^ Top I Iminosugars: From Synthesis to Therapeutic Applications static version printer friendly pdf version Indian Bulk Drugs static version printer friendly pdf version Industry Analysis - Changing Dynamics in Worldwide Psychiatric Franchi... static version printer friendly pdf version Innovations in Cardiovascular Disease Management: Latest Surgical Proc... static version printer friendly pdf version Innovative Strategies and Models for R&D Success: The Evolving Network... static version printer friendly pdf version Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Dru... static version printer friendly pdf version Investigator-Initiated Trials: Building Superior IIT Capabilities static version printer friendly pdf version Ion Channel Assays in the Drug Discovery Process static version printer friendly IT Software Tools for Life Science and Drug Discovery R&D static version printer friendly pdf version ^ Top K Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerg... static version printer friendly pdf version KeywordPharma Conference Insights - Accelerating Patient Recruitment i... static version printer friendly pdf version Knowledge Management Tools for Drug Discovery static version printer friendly pdf version ^ Top L Licensing in Antibacterial R&D - Filling the Gaps static version printer friendly ^ Top M Male and female sexual dysfunction: Blockbuster indication for multipl... static version printer friendly Market Opportunities and Challenges for Antibody Arrays and Beads: A M... static version printer friendly Market Research of Diabetes and its Treatment Medicine-Insulin in Chin... static version printer friendly pdf version Mass Spectrometry in Drug Metabolism and Pharmacokinetics static version printer friendly pdf version Mastering Phase IV Clinical Trials static version printer friendly pdf version Maximizing R&D Productivity: Getting More Bang For Your R&D Buck static version printer friendly pdf version Medication Reconciliation Strategies to Reduce Hospital Adverse Drug E... static version printer friendly pdf version Medicinal Chemistry: An Introduction, 2nd Edition static version printer friendly pdf version Melanoma Therapeutics: Which Strategy Will Take Us There? static version printer friendly Model Organisms in Drug Discovery and Development: An Industry Analys... static version printer friendly Molecular Biomarkers for Clinical Diagnostics and Drug Discovery and D... static version printer friendly Molecular Therapeutics: 21st Century Medicine static version printer friendly pdf version ^ Top N Nanotechnology for Drug Discovery and Drug Design static version printer friendly Narrowing the Innovation Gap with Fragment-Based Drug Discovery and De... static version printer friendly pdf version Navigating the Drug Discovery Landscape: A Strategic Overview of Pharm... static version printer friendly pdf version Neurological Disease: Early-Stage R&D and Dealmaking static version printer friendly pdf version New Drug Development: A Regulatory Overview (8th Edition) static version printer friendly pdf version New Drug Discovery and Development static version printer friendly pdf version New Options for Treating Neurological Disease: Stem Cell Therapy static version printer friendly pdf version New Strategies Combating Bacterial Infection static version printer friendly pdf version Next Generation Drugs: Acceleration Through Innovation static version printer friendly Next-Generation Biologics: Improving on Monoclonal Antibodies static version printer friendly pdf version Next-Generation Genome Sequencing : Towards Personalized Medicine static version printer friendly pdf version Novel Targets in Drug Discovery static version printer friendly pdf version Nuclear Receptors in Drug Metabolism static version printer friendly pdf version Number of Drugs in Preclinical Testing by Year, 1995-2004 static version printer friendly pdf version Nutrition: Science and Applications with Booklet Package static version printer friendly pdf version ^ Top O Obesity Drug Discoveries: What the Future Holds static version printer friendly pdf version Obesity Drug Discoveries: What The Future Holds + Obesity Tracker static version printer friendly pdf version Obesity Drug Discovery: Success and Challenges for a New Pharmaceutica... static version printer friendly pdf version Obesity Therapeutics: Understanding Market Dynamics (Presentation) static version printer friendly pdf version Opportunities for Bioinformatics in European Drug Discovery Markets static version printer friendly pdf version Optimizing the Clinical Trial Process: Strategies to Reduce Costs and ... static version printer friendly Outlook for the Migraine Market With Novel Approaches Limited, Triptan... static version printer friendly pdf version Outsourcing Drug Discovery to China and India static version printer friendly pdf version Outsourcing Opportunities in India and China (Two Reports) static version printer friendly pdf version Overcoming Challenges in Antibacterial Drug Discovery and Development static version printer friendly pdf version Overview of the European Drug Discovery Market static version printer friendly pdf version ^ Top P Partnership in Clinical Trials: Pharmaceutical Company and Managed Car... static version printer friendly Patent Protection Strategies: Maximising Product Revenues static version printer friendly pdf version Pathway Analysis for Drug Discovery: Computational Infrastructure and ... static version printer friendly pdf version Pediatric Drug Development: Concepts and Applications static version printer friendly pdf version Peptides as Drugs: Discovery and Development static version printer friendly pdf version Peripheral Neuropathy and Neuropathic Pain static version printer friendly pdf version Personalized Medicine: The Impact of Pharmacogenomics on Pharmaceutica... static version printer friendly Pharma R&D: Lessons Learned for Future Growth static version printer friendly Pharmaceutical Innovation: An Analysis Of Leading Companies And Strate... static version printer friendly pdf version Pharmaceutical R&D Outsourcing Strategies: An Analysis of Market Drive... static version printer friendly pdf version Pharmacogenomics for Clinical Use and in Drug Development static version printer friendly pdf version Pipeline Insight: ADHD - Shire Driving Diversity in ADHD static version printer friendly Pipeline Insight: Antithrombotics - Reaching The Untreated Prophylaxis... static version printer friendly pdf version Pipeline Insight: Asthma/COPD/Allergic Rhinitis - As Patents Expire, N... static version printer friendly Pipeline Insight: Disease Modification In Rheumatoid Arthritis - Compe... static version printer friendly pdf version Pipeline Insight: Dyslipidemia - Pipeline Agents Unlikely To Rejuvenat... static version printer friendly pdf version Pipeline Insight: Hepatitis B - New Kids On The Block static version printer friendly Pipeline Insight: Hepatitis C - Small Molecules, Big Revolution static version printer friendly Pipeline Insight: Insomnia - Targeting The Sleep Maintenance Market static version printer friendly pdf version Pipeline Insight: Neuropathic Pain - Pipeline Drugs Fail To Nail Neuro... static version printer friendly pdf version Post Genome Project Era Proteomics R&D Competition static version printer friendly Post-ADA Report - Coverage and Analysis of Highlighted Data Presented ... static version printer friendly pdf version Preclinical Safety Evaluation of Biopharmaceuticals: A Science-Based A... static version printer friendly pdf version Prospects for the Phase III Bapineuzumab Trial static version printer friendly pdf version Proteases as Drug Targets: Technologies and Opportunities for Drug Dis... static version printer friendly Protein Arrays: Commercial Opportunities, Legal Trends, and Technology... static version printer friendly pdf version Protein Targeting with Small Molecules: Chemical Biology Techniques an... static version printer friendly pdf version Psychiatric Drugs: New Developments and Market Analysis by Drug Class ... static version printer friendly ^ Top R R and D Ratios and Budgets static version printer friendly R&D Pipeline News - Technology Edition static version printer friendly pdf version R&D Pipeline News - Therapeutic Area Edition static version printer friendly pdf version R&D Update: What's on the Horizon for the Panic Disorder Market? static version printer friendly pdf version Rapid Viral Testing static version printer friendly Regulatory Hurdles in European Drug Discovery static version printer friendly pdf version Repositioning ADME Studies: A Strategy to Reduce Drug Attrition static version printer friendly pdf version Research and Development Growth Trends  static version printer friendly Retinoids : An A-Z guide to their biology, therapeutic opportunities a... static version printer friendly Revenue Structure and Contract Models for Transgenic Manufacturing and... static version printer friendly Rheumatoid Arthritis Drug Discoveries: What The Future Holds static version printer friendly pdf version RNA Interference for Drug R&D: Applications, Alliances, Companies and ... static version printer friendly pdf version RNAi: Broad Application, Expansive Opportunity, 2nd Edition static version printer friendly pdf version ^ Top S Sector Snapshot: Contract Drug Discovery Industry static version printer friendly pdf version SNP Detection: Developing Technologies and Market Strategies static version printer friendly Solving Drug Discovery with Metabolomics and Metabonomics: New Aspects... static version printer friendly pdf version Statistical Issues in Drug Development, 2nd Edition static version printer friendly pdf version Strategic Analysis of Drug Discovery Outsourcing Markets in Europe static version printer friendly pdf version Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Di... static version printer friendly pdf version Strategic Analysis of Pharmaceutical Excipients Market in Europe static version printer friendly pdf version Strategic Analysis of the ADME/TOX Technologies Market in Europe static version printer friendly pdf version Strategic Analysis of the Age-Related Macular Degeneration; Diabetic R... static version printer friendly pdf version Strategic Analysis of World Combinatorial Chemistry Markets static version printer friendly pdf version Strategic Analysis of World Drug Discovery Spending static version printer friendly pdf version Strategic Analysis of World Emerging Neurological Therapeutics Markets... static version printer friendly pdf version Strategic Assessment of HTS in the Asia Pacific Life Sciences Market static version printer friendly pdf version Strategic Perspectives 2001: Ovarian Cancer - Overview of Current and ... static version printer friendly pdf version Strategic Perspectives: Non-Hodgkin’s Lymphoma A Market Galvanized by ... static version printer friendly Streamlining Clinical Trials static version printer friendly pdf version Structure, Function and Modulation of Neuronal Voltage-Gated Ion Chann... static version printer friendly pdf version Structure-Guided Drug Design: Rediscovering the Importance of Drug Str... static version printer friendly Synthetic Biology: An Emerging Tool for Drug Discovery and Production static version printer friendly pdf version ^ Top T Targeting endogenous inhibitors of apoptosis: Opportunities for the tr... static version printer friendly Targeting Kinases for Drug Discovery static version printer friendly pdf version Technology Meets Drug Discovery: The Bioinformatics Revolution static version printer friendly The Anemia Market: Biogenerics and Second-Generation Products Drive Ch... static version printer friendly pdf version The Blockbuster Drugs Outlook: Optimum management strategies throughou... static version printer friendly pdf version The Drug Delivery Outlook 2001 static version printer friendly pdf version The Drug Discovery Outlook: Drivers of innovation in the 21st Century static version printer friendly The Emerging Role of Postmarketing Clinical Research: Regulatory issue... static version printer friendly pdf version The Future of Biobanks: Regulation, Ethics, Investment and the Humaniz... static version printer friendly pdf version The Future of RNAi Therapeutics: Drug Pipelines and Prospects static version printer friendly pdf version The Genomics Outlook To 2005: Transforming Pharmaceutical And Diagnost... static version printer friendly The Global Bioinformatics Industry static version printer friendly pdf version The Global Functional Genomics Industry static version printer friendly The Organic Chemistry of Drug Synthesis, Volume 7 static version printer friendly pdf version The Role of Nanotechnology in European Drug Discovery static version printer friendly pdf version The Top 10 Contract Research Organizations: Positioning, Performance a... static version printer friendly pdf version The Top 100 Contract Research Organisations In Europe static version printer friendly pdf version The Top 20 Contract Research Organisations In Eastern Europe static version printer friendly pdf version The Top 20 Contract Research Organisations In Europe For Ophthalmic Di... static version printer friendly pdf version The Top 20 Contract Research Organisations In The United Kingdom static version printer friendly pdf version The Top 25 Contract Research Organisations In Germany & France static version printer friendly pdf version The Top 50 Contract Research Organisations In Europe For Cardiovascula... static version printer friendly pdf version The Transgenic Plant Market: Profits from New Products and Novel Drugs... static version printer friendly The Virtual Genome: From Genes to Drugs Via the Internet static version printer friendly Therapeutic and Pharmaceutical Opportunities for Osteoporosis and Athe... static version printer friendly pdf version Therapeutic Clinical Intelligence - Psoriasis static version printer friendly pdf version Therapeutic protein industry - value mapping static version printer friendly pdf version Therapeutic Vaccines for Cancer: On the Threshold of Success static version printer friendly Tissue MicroArrays: Emerging Business Opportunities and Applications D... static version printer friendly Transforming Clinical Development Performance through Benchmarking and... static version printer friendly Transforming Drug Discovery through Genomics and Proteomics static version printer friendly pdf version Translational Medicine in Biopharmaceutical R&D: Enabling R&D Optimiza... static version printer friendly pdf version Trends in Diabetes Treatments and Obesity static version printer friendly pdf version ^ Top U U.S. ADME/Tox in Drug Development Markets static version printer friendly pdf version U.S. Next Generation Bio-Tools for Accelerating Bio-Pharmaceutical Dru... static version printer friendly Understanding Chiral Technologies static version printer friendly pdf version Uniting R&D and Marketing for Integrated Early-Stage Market Preparatio... static version printer friendly pdf version ^ Top V Vaccine Adjuvants and Delivery Systems static version printer friendly pdf version Virtual Screening Opportunities in Drug Discovery in Europe static version printer friendly pdf version ^ Top W What Is the Future Role of Predictive Safety Biomarkers in Drug Develo... static version printer friendly pdf version World ADME/Tox in Drug Development Markets static version printer friendly pdf version World Drug Discovery Contract Research Markets - A Strategic Analysis ... static version printer friendly pdf version World Drug Discovery Contract Research Markets: Profiles of the Top 50... static version printer friendly pdf version World Drug Discovery Technologies Markets Outlook static version printer friendly pdf version World Market for Drug Discovery Informatics, 2004-2010 static version printer friendly pdf version World Robotics in Biology: Liquid Handling Markets static version printer friendly pdf version Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug D... static version printer friendly pdf version Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug D... static version printer friendly pdf version Worldwide Drug Discovery R&D static version printer friendly All rights reserved. © copyright 2008 Research and Markets Terms and conditions Privacy Policy